2020 Annual Meeting | C45 - Clinical EMG 3: Practical Applications of EMG in Neuromuscular Disease

Date Sunday 04/26/20

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kelly G. Gwathmey, MD

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should become more famililiar with how to differentiate common neuromuscular disorders based on electrodiagnostic patterns. Patients will also learn the frequently used electrodiagnostic criteria for anterior horn cell disorders and polyneuropathies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:35 AM	Speaker	Electrodiagnostic Approach to Anterior Horn Cell Disorders and Radiculopathies Mohammad Salajegheh, MD, FAAN
07:35 AM - 07:40 AM	Q&A	Questions and Answers Mohammad Salajegheh, MD, FAAN
07:40 AM - 08:15 AM	Speaker	Electrodiagnostic Approach to Polyneuropathies and Mononeuropathies Kelly G. Gwathmey, MD
08:15 AM - 08:20 AM	Q&A	Questions and Answers Kelly G. Gwathmey, MD
08:20 AM - 08:55 AM	Speaker	Electrodiagnostic Approach to Neuromuscular Junction Disorders and Myopathies Aaron E. Izenberg, MD
08:55 AM - 09:00 AM	Q&A	Questions and Answers Aaron E. Izenberg, MD

Faculty Disclosures
Mohammad Salajegheh, MD, FAAN	Dr. Salajegheh has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with US Department of Veterans Affairs. Dr. Salajegheh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with CRICO.
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Aaron E. Izenberg, MD	Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam.

��ɫ��

��ɫ��